Theo H van der Kwast
Overview
Explore the profile of Theo H van der Kwast including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
4986
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beijert I, Hagberg O, Gardmark T, Holmberg L, Haggstrom C, Johnston A, et al.
Eur Urol
. 2024 Aug;
86(5):391-399.
PMID: 39209674
Grade is an important determinant of progression in non-muscle-invasive bladder cancer. Although the World Health Organization (WHO) 2004/2016 grading system is recommended, other systems such as WHO1973 and WHO1999 are...
2.
van Gennep E, Claps F, Bostrom P, Shariat S, Neuzillet Y, Zlotta A, et al.
Bladder Cancer
. 2024 Aug;
10(2):119-132.
PMID: 39131875
Background: Prognostic tools in pathological-node (pN) patients after radical cystectomy (RC) are needed. Objectives: To evaluate the prognostic impact of lymph node (LN)-density on disease-specific survival (DSS) in patients with...
3.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Int Urol Nephrol
. 2023 Nov;
56(4):1323-1333.
PMID: 37980689
Purpose: A re-transurethral resection of the bladder (re-TURB) is a well-established approach in managing non-muscle invasive bladder cancer (NMIBC) for various reasons: repeat-TURB is recommended for a macroscopically incomplete initial...
4.
Beijert I, Cheng L, Liedberg F, Plass K, Williamson S, Gontero P, et al.
Eur Urol Open Sci
. 2023 Jun;
52:154-165.
PMID: 37284047
Background: Grade of non-muscle-invasive bladder cancer (NMIBC) is an important prognostic factor for progression. Currently, two World Health Organization (WHO) classification systems (WHO1973, categories: grade 1-3, and WHO2004 categories: papillary...
5.
Sylvester R, Rodriguez O, Hernandez V, Turturica D, Bauerova L, Bruins H, et al.
Eur Urol
. 2023 Feb;
83(5):e140-e141.
PMID: 36841687
No abstract available.
6.
Claps F, van de Kamp M, Mayr R, Bostrom P, Shariat S, Hippe K, et al.
BJU Int
. 2023 Feb;
132(2):170-180.
PMID: 36748180
Objectives: To evaluate variant histologies (VHs) for disease-specific survival (DSS) in patients with invasive urothelial bladder cancer (BCa) undergoing radical cystectomy (RC). Materials And Methods: We analysed a multi-institutional cohort...
7.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Eur Urol Oncol
. 2023 Jan;
6(2):214-221.
PMID: 36670042
Background: Ta grade 3 (G3) non-muscle-invasive bladder cancer (NMIBC) is a relatively rare diagnosis with an ambiguous character owing to the presence of an aggressive G3 component together with the...
8.
Meijer D, Ettema R, van Leeuwen P, van der Kwast T, van der Poel H, Donswijk M, et al.
BJU Int
. 2022 Sep;
131(3):330-338.
PMID: 36069585
Objectives: To investigate whether patients with suspected pelvic lymph node metastases (molecular imaging [mi] N1) on staging prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) had a different oncological...
9.
Kench J, Amin M, Berney D, Comperat E, Cree I, Gill A, et al.
Histopathology
. 2022 Jun;
81(4):447-458.
PMID: 35758185
The fifth edition of the WHO Classification of Tumours of the Urinary and Male Genital Systems encompasses several updates to the classification and diagnosis of prostatic carcinoma as well as...
10.
Beijert I, Hentschel A, Brundl J, Comperat E, Plass K, Rodriguez O, et al.
Eur Urol Focus
. 2022 May;
8(6):1627-1634.
PMID: 35577750
Background: The pathological existence and clinical consequence of stage T1 grade 1 (T1G1) bladder cancer are the subject of debate. Even though the diagnosis of T1G1 is controversial, several reports...